Total Payments
$10,508
2024 Payments
$192.41
Companies
26
Transactions
549
Medicare Patients
1,124
Medicare Billing
$241,265
Payment Breakdown by Category
Food & Beverage$8,595 (81.8%)
Other$1,720 (16.4%)
Education$192.98 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,595 | 544 | 81.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,720 | 3 | 16.4% |
| Education | $192.98 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $3,218 | 111 | $0 (2020) |
| ABBVIE INC. | $1,365 | 79 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,260 | 68 | $0 (2021) |
| Shire North American Group Inc | $756.62 | 65 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $736.78 | 64 | $0 (2021) |
| Lundbeck LLC | $613.36 | 31 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $478.27 | 18 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $361.07 | 22 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $306.03 | 16 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $183.84 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $192.41 | 7 | Teva Pharmaceuticals USA, Inc. ($101.49) |
| 2023 | $347.66 | 31 | ABBVIE INC. ($240.77) |
| 2022 | $739.36 | 34 | ABBVIE INC. ($720.62) |
| 2021 | $753.96 | 44 | AbbVie Inc. ($355.95) |
| 2020 | $954.22 | 63 | Allergan, Inc. ($478.42) |
| 2019 | $2,006 | 133 | Takeda Pharmaceuticals U.S.A., Inc. ($577.45) |
| 2018 | $3,943 | 128 | Allergan Inc. ($2,137) |
| 2017 | $1,572 | 109 | Takeda Pharmaceuticals America, Inc. ($361.07) |
All Payment Transactions
549 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/03/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $101.49 | General |
| 04/05/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/07/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $4.07 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/15/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.74 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: NEUROSCIENCE | ||||||
| 06/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/24/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 161 | 602 | $90,300 | $55,202 |
| 2022 | 3 | 321 | 707 | $97,600 | $58,334 |
| 2021 | 2 | 340 | 1,240 | $124,000 | $75,765 |
| 2020 | 2 | 302 | 1,014 | $101,400 | $51,963 |
Total Patients
1,124
Total Services
3,563
Medicare Billing
$241,265
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 161 | 602 | $90,300 | $55,202 | 61.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 166 | 538 | $80,700 | $52,012 | 64.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 91 | $9,100 | $3,433 | 37.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 72 | 78 | $7,800 | $2,889 | 37.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 179 | 711 | $71,100 | $47,150 | 66.3% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 161 | 529 | $52,900 | $28,615 | 54.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 178 | 688 | $68,800 | $35,289 | 51.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 124 | 326 | $32,600 | $16,673 | 51.1% |
About Walter Fitzhugh, M.D., M.P.H
Walter Fitzhugh, M.D., M.P.H is a Addiction Medicine healthcare provider based in Lincoln, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518973148.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Walter Fitzhugh, M.D., M.P.H has received a total of $10,508 in payments from pharmaceutical and medical device companies, with $192.41 received in 2024. These payments were reported across 549 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($8,595).
As a Medicare-enrolled provider, Fitzhugh has provided services to 1,124 Medicare beneficiaries, totaling 3,563 services with total Medicare billing of $241,265. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction Medicine
- Other Specialties Addiction Medicine
- Location Lincoln, RI
- Active Since 08/01/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084A0401X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518973148
Products in Payments
- VRAYLAR (Drug) $4,570
- Trintellix (Drug) $1,402
- LATUDA (Drug) $736.78
- REXULTI (Drug) $486.54
- TRINTELLIX (Drug) $415.58
- MYDAYIS (Drug) $388.63
- VYVANSE (Drug) $321.65
- NUEDEXTA (Drug) $306.03
- AUSTEDO (Drug) $250.27
- BRINTELLIX (Drug) $160.36
- CAPLYTA (Drug) $145.17
- SUNOSI (Drug) $139.23
- NEUROSTAR TMS THERAPY (Device) $125.63
- Azstarys (Drug) $100.63
- Brainsway Deep TMS (Device) $88.62
- BELSOMRA (Drug) $74.72
- Fanapt (Drug) $73.05
- INGREZZA (Drug) $71.50
- HETLIOZ (Drug) $61.42
- SPRAVATO (Drug) $45.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.